Opportunity
Federal Register #2026-22725
BIS seeks comments on specialty pharmaceutical import tariff information collection
Buyer
Department of Commerce, Bureau of Industry and Security
Posted
November 06, 2026
Respond By
January 06, 2027
Identifier
2026-22725
The Department of Commerce is seeking comments on a specialty-pharmaceutical import tariff information collection, not procuring products or services. - Government buyer: U.S. Department of Commerce, Bureau of Industry and Security (BIS). - Purpose: Gather comments on information BIS would collect from companies seeking a zero-percent tariff rate for qualifying specialty pharmaceuticals and related ingredients under Section 232 adjustments. - Requested information: Organization details; product description and HTSUS classification; country of origin; importer of record; and evidence of an urgent U.S. health need, including the disease treated, alternative therapies, and estimated number of domestic patients. - Estimated reporting burden: 250 respondents, one response per year, eight hours per response, and 2,000 total annual burden hours. OMB Control Number 0694-0150. - Procurement details: No products, services, OEMs, vendors, quantities, or contract value are identified.
Description
The Department of Commerce invites public and federal agency comments on an information collection under the Paperwork Reduction Act. The notice provides a 60-day comment period for the OMB-approved emergency collection associated with Section 232 adjustments to imports of specialty pharmaceuticals and related ingredients. Companies seeking a zero-percent tariff rate for qualifying products must submit information about their organization, the imported product, and how it meets an urgent health need. Comments are due January 5, 2027.